Misplaced Pages

Luliconazole

Clinical data
Trade names	Luzu, Luzarn, Lulicon, LULY, Zyluli,Luris
Routes of administration	Topical
ATC code	D01AC18 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Pharmacokinetic data
Protein binding	>99%
Identifiers
IUPAC name (2E)-(1H-imidazol-1-yl)acetonitrile
CAS Number	187164-19-8
PubChem CID	3003141
ChemSpider	2273807
UNII	RE91AN4S8G
CompTox Dashboard (EPA)	DTXSID3048607
Chemical and physical data
Formula	C14H9Cl2N3S2
Molar mass	354.27 g·mol
3D model (JSmol)	Interactive image
SMILES C1(S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl
InChI InChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1 Key:YTAOBBFIOAEMLL-REQDGWNSSA-N

Luliconazole, trade names Luzu among others, is an imidazole antifungal medication. As a 1% topical cream, It is indicated for the treatment of athlete's foot, jock itch, and ringworm caused by dermatophytes such as Trichophyton rubrum, Microsporum gypseum, and Epidermophyton floccosum.

References

1. ^ "LUZU (luliconazole) Cream, 1%. Full Prescribing Information" (PDF). Valeant Pharmaceuticals North America LLC. Retrieved 1 October 2015.
2. Gupta AK, Daigle D (2016). "A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections". Infection and Drug Resistance. 9: 1–6. doi:10.2147/IDR.S61998. PMC 4723097. PMID 26848272.
3. "FDA approves luliconazole for tinea pedis". November 19, 2013. Archived from the original on 16 January 2014. Retrieved 14 January 2014.

External links

• [REDACTED] Media related to Luliconazole at Wikimedia Commons

This dermatologic drug article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• 1,3-Dithiolanes
• Nitriles
• Chlorobenzene derivatives
• Antifungals
• Fungicides
• Lanosterol 14α-demethylase inhibitors
• Dermatologic drug stubs